focus -WSS

focus

author：comprehensive 2025-08-19 20:44:58 - browse：6842

Bernard Moss, a research scientist at NIAID. -- Infectious disease coverage from STAT — Bernard Moss Courtesy NIAID

For more than half a century, scientist Bernard Moss has been commanding the attention of peers interested in prying biological secrets from poxviruses and other microbiological targets. Now he’s commanding the attention of a different audience: House Republicans.

Moss, who will mark his 86th birthday in late July and who goes by Bernie, has worked for more than 55 years in the laboratories of the National Institute of Allergy and Infectious Diseases in Bethesda, Md. Over that time, he has been investigating viruses in relative anonymity — except, that is, among the virological cognoscenti.

But last year, in an interview with Science, Moss said he planned to try to determine why one strain of mpox viruses, known as Clade 1, is so much more virulent than those in a second strain, Clade 2, by taking genes from the former and putting them into the latter. Clade 2 viruses are responsible for the ongoing mpox outbreak first detected in May 2022.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Attacks on the drug industry will lead to fewer breakthroughs

WSS

Humana, CVS hope to turn members into patients at clinics

Attacks on the drug industry will lead to fewer breakthroughs

ProMED, early warning system on disease outbreaks, in peril

Search called off for baby washed away in Pennsylvania flash flood

What causes rare myocarditis in young men after Covid vaccines?

Dems pitch expanding Medicare power to negotiate drug prices

hotspot

focus

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

New Alzheimer's drugs heat up race for early detection blood tests

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Nearly two

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Humana, CVS hope to turn members into patients at clinics

Peter Hotez and the public health issue of online harassment

Dems pitch expanding Medicare power to negotiate drug prices

Cancer drug shortages should be causing more outrage

OTC birth control: A brief history of over the counter pill design

focus

The drug industry sees a key ally in the Senate prevail

The haunting brain science of long Covid

What the cancer research community can learn from the Covid response

ER docs worry over extreme heat as a 'mass casualty event'

Nearly two

What to watch for from Zogenix and Amicus clinical trials

explore

knowledge

entertainment

focus